Invesco’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$560K Buy
181,084
+41,622
+30% +$129K ﹤0.01% 3109
2025
Q1
$487K Buy
139,462
+69,631
+100% +$243K ﹤0.01% 3149
2024
Q4
$228K Buy
69,831
+3,780
+6% +$12.4K ﹤0.01% 3478
2024
Q3
$254K Buy
66,051
+4,924
+8% +$19K ﹤0.01% 3448
2024
Q2
$189K Buy
61,127
+1,589
+3% +$4.91K ﹤0.01% 3623
2024
Q1
$154K Buy
59,538
+2,865
+5% +$7.39K ﹤0.01% 3678
2023
Q4
$142K Buy
56,673
+58
+0.1% +$145 ﹤0.01% 3620
2023
Q3
$115K Buy
56,615
+3,075
+6% +$6.24K ﹤0.01% 3684
2023
Q2
$123K Buy
53,540
+6,585
+14% +$15.1K ﹤0.01% 3675
2023
Q1
$142K Buy
46,955
+1,596
+4% +$4.84K ﹤0.01% 3655
2022
Q4
$106K Buy
45,359
+7,394
+19% +$17.2K ﹤0.01% 3790
2022
Q3
$72K Buy
37,965
+2,925
+8% +$5.55K ﹤0.01% 3855
2022
Q2
$95K Buy
35,040
+8,142
+30% +$22.1K ﹤0.01% 3867
2022
Q1
$80K Buy
26,898
+1,513
+6% +$4.5K ﹤0.01% 3849
2021
Q4
$99K Sell
25,385
-3,795
-13% -$14.8K ﹤0.01% 3869
2021
Q3
$126K Buy
29,180
+3,994
+16% +$17.2K ﹤0.01% 3863
2021
Q2
$76K Buy
+25,186
New +$76K ﹤0.01% 3894
2018
Q1
Sell
-117,321
Closed -$592K 3689
2017
Q4
$592K Buy
117,321
+4,394
+4% +$22.2K ﹤0.01% 3228
2017
Q3
$700K Buy
112,927
+14,837
+15% +$92K ﹤0.01% 3179
2017
Q2
$353K Sell
98,090
-710
-0.7% -$2.56K ﹤0.01% 3432
2017
Q1
$321K Buy
+98,800
New +$321K ﹤0.01% 3485
2015
Q3
Sell
-430,408
Closed -$5.1M 3750
2015
Q2
$5.1M Buy
430,408
+125,642
+41% +$1.49M ﹤0.01% 1970
2015
Q1
$5.32M Buy
304,766
+301,311
+8,721% +$5.26M ﹤0.01% 1931
2014
Q4
$52K Sell
3,455
-3,476
-50% -$52.3K ﹤0.01% 3904
2014
Q3
$147K Sell
6,931
-227
-3% -$4.81K ﹤0.01% 3767
2014
Q2
$93K Buy
+7,158
New +$93K ﹤0.01% 3912